Postmenopausal Symptoms Clinical Trial
Official title:
Chronic Effects of Estrogen in Microcirculation and Insulin Resistance in Postmenopausal Obese Women
This study aims to evaluate the chronic effects of estrogen on microcirculation, inflammatory biomarkers, hormonal status, plasma viscosity and biochemical tests in postmenopausal obese women after three months of follow-up intervention.
Estrogens exert pleiotropic actions on the cardiovascular system through binding to estrogen
receptors. Traditionally, estrogen receptors have been recognized as transcription factors
regulating the expression of target genes, however, numerous studies have revealed rapid
actions of estrogen in different systems, so-called 'extranuclear actions'. At this level,
estrogen triggers rapid vasodilatation, exerts anti-inflammatory effects, regulates vascular
cell growth and migration, and confers protection to cardiomyocytes. Our aims are to
investigate estrogen´s chronic effects on microcirculation.
The study will assess the potential benefits of estrogens on: chronic low-grade
inflammation, metabolic profile, microcirculation and blood rheology. Postmenopausal obese
women will be randomly submitted to estrogen (transdermal 17-β-estradiol 1mg/day) or placebo
therapy during three months in a double-blind fashion. At baseline and after intervention,
nailfold videocapillaroscopy, laser-Doppler flowmetry and venous occlusion plethysmography,
inflammatory biomarkers, hormonal status, metabolic profile, plasma viscosity and
anthropometrical measures will be assessed in all subjects.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06369363 -
Estrogen Deficiency on Cardiovascular Risk
|
Early Phase 1 | |
Not yet recruiting |
NCT01170195 -
Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms
|
Phase 1/Phase 2 | |
Completed |
NCT00535288 -
Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)
|
Phase 3 | |
Recruiting |
NCT06030388 -
Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women
|
N/A | |
Not yet recruiting |
NCT05557799 -
Photobiomodulation in Post Menopause Genitourinary Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT04893226 -
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
|
N/A | |
Completed |
NCT03684096 -
Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes
|
N/A | |
Completed |
NCT01268046 -
Aging and Estrogen on Cortical Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05659693 -
The Effect of Digital Literacy Education Given to Postmenopausal Women on Health Literacy and Quality of Life
|
N/A | |
Completed |
NCT03572153 -
A Mind-Body Intervention for Hot Flash Management
|
N/A | |
Not yet recruiting |
NCT06419972 -
Multimodal Program for Climacteric Women
|
N/A | |
Not yet recruiting |
NCT06197568 -
Open-Label Study of Vaginal AZU-101 in Postmenopausal Women
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03854396 -
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
|
Phase 3 | |
Completed |
NCT01361308 -
Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
|
Phase 3 | |
Unknown status |
NCT00905723 -
The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women
|
Phase 3 | |
Recruiting |
NCT05351476 -
Exercise Training and Fat Metabolism in Postmenopausal Women
|
N/A | |
Completed |
NCT06096818 -
Kegel and Abdominal Exercises on Urinary Incontinence Severity, Quality of Life, and Sleep Quality in Menopausal Women
|
N/A | |
Completed |
NCT03150407 -
Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness
|
N/A | |
Recruiting |
NCT06220266 -
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
|
Phase 2/Phase 3 | |
Recruiting |
NCT04129060 -
Cholinergic Health After Menopause (CHAMP)
|
Early Phase 1 |